N-OXIDATION OF DRUGS ASSOCIATED WITH IDIOSYNCRATIC DRUG REACTIONS

REFERENCES

• Pohl L.R., Satoh H., Christ D.D., Kenna J.G. The Immunologic and Metabolic Basis of Drug Hypersensitivities. Ann. Rev. Pharmacol. 1988; 28: 367–387
   Google Scholar
• Park B.K., Pirmohamed M., Kitteringham N.R. Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective. Chem. Res. Toxicol. 1998; 11: 969–988
   PubMed Web of Science ®Google Scholar
• Uetrecht J.P. New Concepts in Immunology Relevant to Idiosyncratic Drug Reactions: The “Danger Hypothesis” and Innate Immune System. Chem. Res. Toxicol. 1999; 12: 387–395
   PubMed Web of Science ®Google Scholar
• Landsteiner K., Jacobs J. Studies on the Sensitization of Animals with Simple Chemical Compounds. J. Exp. Med. 1935; 61: 643–656
   PubMedGoogle Scholar
• Zanni M.P., von Greyerz S., Schnyder B., Brander K.A., Frutig K., Hari Y., Valitutti S., Pichler W.J. HLA-Restricted, Processing- and Metabolism-Independent Pathway of Drug Recognition by Human Alphabeta T Lymphocytes. J. Clin. Investig. 1998; 102: 1591–1598
   PubMed Web of Science ®Google Scholar
• Uetrecht J.P. Reactivity and Possible Significance of Hydroxylamine and Nitroso Metabolites of Procainamide. J. Pharmacol. Exp. Ther. 1985; 232: 420–425
   PubMed Web of Science ®Google Scholar
• Cribb A.E., Miller M., Tesoro A., Spielberg S.P. Peroxidase-Dependent Oxidation of Sulfonamides by Monocytes and Neutrophils from Humans and Dogs. Mol. Pharmacol. 1990; 38: 744–751
   PubMed Web of Science ®Google Scholar
• Uetrecht J.P., Zahid N. N-Chlorination And Oxidation of Procainamide by Myeloperoxidase: Toxicological Implications. Chem. Res. Toxicol. 1991; 4: 218–222
   PubMed Web of Science ®Google Scholar
• Hope R.R., Bates L.A. The Frequency of Procainamide-Induced Systemic Lupus Erythematosus. Med. J. Aust. 1972; 2: 298–303
   PubMed Web of Science ®Google Scholar
• Riley R.J., Leeder J.S. In Vitro Analysis of Metabolic Predisposition to Drug Hypersensitivity Reactions. Clin. Exp. Immunol. 1995; 99: 1–6
   PubMed Web of Science ®Google Scholar
• Kromann N.P., Vilhelmsen R., Stahl D. The Dapsone Syndrome. Arch. Dermatol. 1982; 118: 531–532
   PubMed Web of Science ®Google Scholar
• Salama A., Mueller-Eckhardt C. The Role of Metabolite-Specific Antibodies in Nomifensine-Dependent Immune Hemolytic Anemia. N. Engl. J. Med. 1985; 313: 469–474
   PubMed Web of Science ®Google Scholar
• Welbanks L. Compendium of Pharmaceuticals and Specialties. Canadian Pharmacists Association, Ottawa 2001
   Google Scholar
• Knowles S., Shapiro L., Shear N.H. Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides? Revisiting the Meaning of “Sulfa” Allergy. Drug Saf. 2001; 24: 239–247
   PubMed Web of Science ®Google Scholar
• Prystowsky S.D., Allen A.M., Smith R.W., Nonomura J.H., Odom R.B., Akers W.A. Allergic Contact Hypersensitivity to Nickel, Neomycin, Ethylenediamine, and Benzocaine. Relationships Between Age, Sex, History of Exposure, and Reactivity to Standard Patch Tests and Use Tests in a General Population. Arch. Dermatol. 1979; 115: 959–962
   PubMed Web of Science ®Google Scholar
• Rood J.P. Adverse Reaction to Dental Local Anaesthetic Injection—“Allergy” Is Not the Cause. Br. Dent. J. 2000; 189: 380–384
   PubMed Web of Science ®Google Scholar
• Maggs J.L., Naisbitt D.J., Tettey J.N., Pirmohamed M., Park B.K. Metabolism of Lamotrigine to a Reactive Arene Oxide Intermediate. Chem. Res. Toxicol. 2000; 13: 1075–1081
   PubMed Web of Science ®Google Scholar
• Liu Z.C., Uetrecht J.P. Clozapine Is Oxidized by Activated Human Neutrophils to a Reactive Nitrenium Ion That Irreversibly Binds to the Cells. J. Pharmacol. Exp. Ther. 1995; 275: 1476–1483
   PubMed Web of Science ®Google Scholar
• Idanpaan-Heikkila J., Alhava E., Olkinuora M., Palva I.P. Agranulocytosis During Treatment with Clozapine. Eur. J. Clin. Pharmacol. 1977; 11: 193–198
   PubMed Web of Science ®Google Scholar
• Lieberman J.A., Safferman A.Z. Clinical Profile of Clozapine: Adverse Reactions and Agranulocytosis. Psychiatr. Q. 1992; 63: 51–70
   PubMedGoogle Scholar
• Gardner I., Zahid N., MacCrimmon D., Uetrecht J.P. A Comparison of the Oxidation of Clozapine and Olanzapine to Reactive Metabolites and the Toxicity of These Metabolites to Human Leukocytes. Mol. Pharmacol. 1998; 53: 991–998
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B., Sohnle P.G. Generation of Free Radical Intermediates from Foreign Compounds by Neutrophil-Derived Oxidants. J. Clin. Investig. 1985; 75: 1618–1622
   PubMed Web of Science ®Google Scholar
• Dukes M.N.G., Aronson J.K., Blackwell B., Dittmann S., Folb P.I., Hoigne R., Hvidberg E.F., Tester-Dalderup C.B.M., Tognoni G., von Eickstedt K., Westerholm B. Meyler's Side Effects of Drugs. Elsevier, Amsterdam 1988; 111–112
   Google Scholar
• Eling T.E., Mason R.P., Sivarajah K. The Formation of Aminopyrine Cation Radical by Peroxidase Activity of Prostaglandin H Synthase and Subsequent Reactions of the Radical. J. Biol. Chem. 1985; 260: 1601–1607
   PubMed Web of Science ®Google Scholar
• Uetrecht J.P., Ma H.M., MacKnight E., McClelland R. Oxidation of Aminopyrine by Hypochlorite to a Reactive Dication: Possible Implications for Aminopyrine-Induced Agranulocytosis. Chem. Res. Toxicol. 1995; 8: 226–233
   PubMed Web of Science ®Google Scholar
• Hoffman A.M., Butt E.M., Hickey N.G. Neutropenia Following Amidopyrine. J. Am. Med. Assoc. 1934; 102: 1213–1214
   Google Scholar
• Ascherl M., Eyer P., Kampffmeyer H. Formation and Disposition of Nitrosochloramphenicol in Rat Liver. Biochem. Pharmacol. 1985; 34: 3755–3763
   PubMed Web of Science ®Google Scholar
• Scheline R.R. Metabolism of Foreign Compounds by Gastrointestinal Microorganisms. Pharmacol. Rev. 1973; 25: 451–523
   PubMed Web of Science ®Google Scholar
• Wallerstein R.O., Condit P.K., Kasper C.K., Brown J.W., Morrison F.R. Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia. J. Am. Med. Assoc. 1969; 208: 2045–2050
   PubMed Web of Science ®Google Scholar
• Yunis A.A. Chloramphenicol: Relation of Structure to Activity and Toxicity. Ann. Rev. Pharmacol. Toxicol. 1988; 28: 83–100
   PubMed Web of Science ®Google Scholar
• Utili R., Boitnott J.K., Zimmerman H.J. Dantrolene-Associated Hepatic Injury. Incidence and Character. Gastroenterology 1977; 72: 610–616
   PubMed Web of Science ®Google Scholar
• Watkins P. COMT Inhibitors and Liver Toxicity. Neurology 2000; 55: S53–56
   Web of Science ®Google Scholar
• Anders M.W. Bioactivation of Foreign Compounds. Academic Press, Orlando 1985
   Google Scholar
• Hofstra A., Uetrecht J.P. Metabolism of Hydralazine to a Reactive Intermediate by the Oxidizing System of Activated Leukocytes. Chem.–Biol. Interact. 1993; 89: 183–196
   PubMed Web of Science ®Google Scholar
• Hofstra A.H., Matassa L.C., Uetrecht J.P. Metabolism of Hydralazine by Activated Neutrophils: Implications for Hydralazine-Induced Lupus. J. Rheumatol. 1991; 18: 1673–1680
   PubMed Web of Science ®Google Scholar
• Hofstra A.H., Angela Li-Muller S.M., Uetrecht J.P. Metabolism of Isoniazid by Activated Leukocytes: Possible Role in Drug-Induced Lupus. Drug Metab. Dispos. 1992; 20: 205–210
   PubMed Web of Science ®Google Scholar
• Tweedie D.J., Erikson J.M., Prough R.A. Metabolism of Hydrazine Anti-cancer Agents. Pharmacol. Ther. 1987; 34: 111–127
   PubMed Web of Science ®Google Scholar
• Mitchell J.R., Thorgeirsson S.S., Potter W.Z., Jollow D.J., Keiser H. Acetaminophen-Induced Hepatic Injury: Protective Role of Glutathione in Man and Rationale for Therapy. Clin. Pharmacol. Ther. 1974; 16: 676–684
   PubMed Web of Science ®Google Scholar
• Maggs J.L., Kitteringham N.R., Breckenridge A.M., Park B.K. Autoxidative Formation of a Chemically Reactive Intermediate from Amodiaquine, a Myelotoxin and Hepatotoxin in Man. Biochem. Pharmacol. 1987; 36: 2061–2062
   PubMed Web of Science ®Google Scholar
• Uetrecht J.P., Zahid N., Whitfield D. Metabolism of Vesnarinone by Activated Neutrophils; Implications for Vesnarinone-Induced Agranulocytosis. J. Pharmacol. Exp. Ther. 1994; 270: 865–872
   PubMed Web of Science ®Google Scholar
• Liu Z.C., McClelland R.A., Uetrecht J.P. Oxidation of 5-Aminosalicylic Acid by Hypochlorous Acid to a Reactive Metabolite: Possible Role in the Treatment of Inflammatory Bowel Disease. Drug Metab. Dispos. 1995; 23: 246–250
   PubMed Web of Science ®Google Scholar
• Doerge D.R., Divi R.L., Deck J., Taurog A. Mechanism for the Anti-thyroid Action of Minocycline. Chem. Res. Toxicol. 1997; 10: 49–58
   PubMed Web of Science ®Google Scholar
• Lai W.G., Zahid N., Uetrecht J.P. Metabolism of Trimethoprim to a Reactive Iminoquinone Methide by Activated Human Neutrophils and Hepatic Microsomes. J. Pharmacol. Exp. Ther. 1999; 291: 292–299
   PubMed Web of Science ®Google Scholar
• Gough A., Chapman S., Wagstaff K., Emery P., Elias E. Minocycline Induced Autoimmune Hepatitis and Systemic Lupus Erythematosus-Like Syndrome. Br. Med. J. 1996; 312: 169–172
   PubMed Web of Science ®Google Scholar
• Carr A., Penny R., Cooper D.A. Efficacy and Safety of Rechallenge with Low-Dose Trimethoprim-Sulphamethoxazole in Previously Hypersensitive HIV-Infected Patients. AIDS 1993; 7: 65–71
   PubMed Web of Science ®Google Scholar
• Ju C., Uetrecht J.P. Detection of 2-Hydroxyiminostilbene in the Urine of Patients Taking Carbamazepine and Its Oxidation to a Reactive Iminoquinone Intermediate. J. Pharmacol. Exp. Ther. 1999; 288: 51–56
   PubMed Web of Science ®Google Scholar
• Lai W.G., Gardner I., Zahid N., Uetrecht J.P. Bioactivation and Covalent Binding of Hydroxyfluperlapine in Human Neutrophils: Implications for Fluperlapine-Induced Agranulocytosis. Drug Metab. Dispos. 2000; 28: 255–263
   PubMed Web of Science ®Google Scholar
• Ju C., Uetrecht J.P. Oxidation of a Metabolite of Indomethacin (Desmethyldeschlorobenzoylindomethacin) to Reactive Intermediates by Activated Neutrophils, Hypochlorous Acid, and the Myeloperoxidase System. Drug Metab. Dispos. 1998; 26: 676–680
   PubMed Web of Science ®Google Scholar
• Miyamoto G., Zahid N., Uetrecht J.P. Oxidation of Diclofenac to Reactive Intermediates by Neutrophils, Myeloperoxidase, and Hypochlorous Acid. Chem. Res. Toxicol. 1997; 10: 414–419
   PubMed Web of Science ®Google Scholar
• Shear N.H., Spielberg S.P. Anticonvulsant Hypersensitivity Syndrome. J. Clin. Investig. 1988; 82: 1826–1832
   PubMed Web of Science ®Google Scholar
• Donaldson G.W.K., Graham J.G. Aplastic Anemia Following the Administration of Tegretol. Br. J. Clin. Pract. 1965; 19: 699–702
   PubMedGoogle Scholar
• Joffe R.T., Post R.M., Roy-Byrne P.P., Uhde T.W. Hematological Effects of Carbamazepine in Patients with Affective Illness. Am. J. Psychiatry 1985; 142: 1196–1199
   PubMed Web of Science ®Google Scholar
• Fischer-Cornelssen K.A. Fluperlapine in 104 Schizophrenic Patients. Open Multicenter Trial. Arzneimittelforschung 1984; 34: 125–130
   PubMed Web of Science ®Google Scholar
• Risks of Agranulocytosis and Aplastic Anemia: A First Report with Special Reference to Analgesics. J. Am. Med. Assoc. 1986; 256: 1749–1757
   PubMed Web of Science ®Google Scholar
• Helfgott S.M., Sandberg-Cook J., Zakim D., Nestler J. Diclofenac-Associated Hepatotoxicity. J. Am. Med. Assoc. 1990; 264: 2660–2662
   PubMed Web of Science ®Google Scholar
• Kretz-Rommel A., Boelsterli U.A. Diclofenac Covalent Protein Binding Is Dependent on Acyl Glucuronide Formation and Is Inversely Related to P450-Mediated Acute Cell Injury in Cultured Rat Hepatocytes. Toxicol. Appl. Pharmacol. 1993; 120: 155–161
   PubMed Web of Science ®Google Scholar
• Cameron H.A., Ramsay L.E. The Lupus Syndrome Induced by Hydralazine: A Common Complication with Low Dose Therapy. Br. Med. J. 1984; 289: 410–412
   PubMed Web of Science ®Google Scholar
• Matzinger P. Tolerance, Danger and the Extended Family. Annu. Rev. Immunol. 1994; 12: 991–1045
   PubMed Web of Science ®Google Scholar